Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Desseigne

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Diagnostic and Interventional Imaging|March 5, 2015
Thrombocytopenia due to hypersplenism in oncological disease: partial splenic embolization during palliative treatmentH Beji, C De La Fouchardière, F Desseigne, et al.
Cancer Research|February 2, 1999
Neurofibromatosis and early onset of cancers in hMLH1-deficient childrenQ Wang, C Lasset, F Desseigne, et al.
Gastroenterologie Clinique Et Biologique|December 11, 1999
[Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost]S Taieb, E Vaillant, P Pommier, et al.
ESMO Open|November 27, 2021
Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trialE Assenat, C de la Fouchardière, F Portales, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective studyE Bonnet, C Mastier, A Lardy-Cléaud, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2007
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastasesM Ychou, F Viret, A Kramar, et al.
Human Genetics|September 10, 1999
Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancerQ Wang, C Lasset, F Desseigne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2013
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trialF C Bidard, F Huguet, C Louvet, et al.
International Journal of Cancer|December 17, 1997
Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC familiesQ Wang, F Desseigne, C Lasset, et al.
British Journal of Cancer|July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancerJ-P Delord, J Bennouna, P Artru, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Diagnostic and Interventional Imaging|March 5, 2015
Thrombocytopenia due to hypersplenism in oncological disease: partial splenic embolization during palliative treatmentH Beji, C De La Fouchardière, F Desseigne, et al.
Cancer Research|February 2, 1999
Neurofibromatosis and early onset of cancers in hMLH1-deficient childrenQ Wang, C Lasset, F Desseigne, et al.
Gastroenterologie Clinique Et Biologique|December 11, 1999
[Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost]S Taieb, E Vaillant, P Pommier, et al.
ESMO Open|November 27, 2021
Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trialE Assenat, C de la Fouchardière, F Portales, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective studyE Bonnet, C Mastier, A Lardy-Cléaud, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2007
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastasesM Ychou, F Viret, A Kramar, et al.
Human Genetics|September 10, 1999
Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancerQ Wang, C Lasset, F Desseigne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2013
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trialF C Bidard, F Huguet, C Louvet, et al.
International Journal of Cancer|December 17, 1997
Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC familiesQ Wang, F Desseigne, C Lasset, et al.
British Journal of Cancer|July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancerJ-P Delord, J Bennouna, P Artru, et al.
Pageof 2